These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9871624)

  • 21. 2-Azetidinone derivatives: design, synthesis and evaluation of cholesterol absorption inhibitors.
    Wang Y; Zhang H; Huang W; Kong J; Zhou J; Zhang B
    Eur J Med Chem; 2009 Apr; 44(4):1638-43. PubMed ID: 18990470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterocyclic ring scaffolds as small-molecule cholesterol absorption inhibitors.
    Ritter T; Kvaernø L; Werder M; Hauser H; Carreira EM
    Org Biomol Chem; 2005 Oct; 3(19):3514-23. PubMed ID: 16172689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fresh from the pipeline. Ezetimibe.
    Earl J; Kirkpatrick P
    Nat Rev Drug Discov; 2003 Feb; 2(2):97-8. PubMed ID: 12572539
    [No Abstract]   [Full Text] [Related]  

  • 24. Identification of binding proteins for cholesterol absorption inhibitors as components of the intestinal cholesterol transporter.
    Kramer W; Glombik H; Petry S; Heuer H; Schäfer H; Wendler W; Corsiero D; Girbig F; Weyland C
    FEBS Lett; 2000 Dec; 487(2):293-7. PubMed ID: 11150527
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and Evaluation of 2-Azetidinone and 1H-Pyrrole-2,5-dione Derivatives as Cholesterol Absorption Inhibitors for Reducing Inflammation Response and Oxidative Stress.
    Xia Y; Zhu L; Yuan X; Wang Y
    Chem Biodivers; 2019 Feb; 16(2):e1800189. PubMed ID: 30230227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple strategies for the preparation of a sulfur-35 labeled NPC1L1 radioligand.
    Simeone JP; Braun MP; Leone JF; Lin P; DeVita RJ; Garcia-Calvo M; Bull HG; Lisnock J; Dean DC
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5033-6. PubMed ID: 19631535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Indium-mediated 1,2,4,5-hexatetraen-3-ylation of 4-acetoxy-2-azetidinones and their applications to the Diels-Alder reactions for the synthesis of 2-azetidinone derivatives.
    Yu H; Lee PH
    J Org Chem; 2008 Jul; 73(13):5183-6. PubMed ID: 18507447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ezetimibe (Schering-Plough).
    Meng CQ
    Curr Opin Investig Drugs; 2001 Mar; 2(3):389-92. PubMed ID: 11575710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enzymatic glucuronidation of a novel cholesterol absorption inhibitor, Sch 58235.
    Zaks A; Dodds DR
    Appl Biochem Biotechnol; 1998; 73(2-3):205-14. PubMed ID: 9779577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs.
    Davis HR; Pula KK; Alton KB; Burrier RE; Watkins RW
    Metabolism; 2001 Oct; 50(10):1234-41. PubMed ID: 11586500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ezetimibe potently inhibits cholesterol absorption but does not affect acute hepatic or intestinal cholesterol synthesis in rats.
    van Heek M; Farley C; Compton DS; Hoos LM; Smith-Torhan A; Davis HR
    Br J Pharmacol; 2003 Apr; 138(8):1459-64. PubMed ID: 12721101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 2-Azetidinone--a new profile of various pharmacological activities.
    Mehta PD; Sengar NP; Pathak AK
    Eur J Med Chem; 2010 Dec; 45(12):5541-60. PubMed ID: 20970895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Azetidinones as zinc-binding groups to design selective HDAC8 inhibitors.
    Galletti P; Quintavalla A; Ventrici C; Giannini G; Cabri W; Penco S; Gallo G; Vincenti S; Giacomini D
    ChemMedChem; 2009 Dec; 4(12):1991-2001. PubMed ID: 19821480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo metabolism-based discovery of a potent cholesterol absorption inhibitor, SCH58235, in the rat and rhesus monkey through the identification of the active metabolites of SCH48461.
    Van Heek M; France CF; Compton DS; McLeod RL; Yumibe NP; Alton KB; Sybertz EJ; Davis HR
    J Pharmacol Exp Ther; 1997 Oct; 283(1):157-63. PubMed ID: 9336320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of intestinal cholesterol absorption with ezetimibe increases components of reverse cholesterol transport in humans.
    Davidson MH; Voogt J; Luchoomun J; Decaris J; Killion S; Boban D; Glass A; Mohammad H; Lu Y; Villegas D; Neese R; Hellerstein M; Neff D; Musliner T; Tomassini JE; Turner S
    Atherosclerosis; 2013 Oct; 230(2):322-9. PubMed ID: 24075764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel cholesterol absorption inhibitor, ezetimibe, decreases adipose-derived and vascular PAI-1 expression in vivo.
    Yamamoto K; Shibayama S; Takeshita K; Kojima T; Takamatsu J
    Thromb Res; 2009 Nov; 124(5):644-5. PubMed ID: 19482339
    [No Abstract]   [Full Text] [Related]  

  • 37. The discovery of ezetimibe: a view from outside the receptor.
    Clader JW
    J Med Chem; 2004 Jan; 47(1):1-9. PubMed ID: 14695813
    [No Abstract]   [Full Text] [Related]  

  • 38. Rabbit small intestine does not contain an annexin II/caveolin 1 complex as a target for 2-azetidinone cholesterol absorption inhibitors.
    Kramer W; Corsiero D; Girbig F; Jähne G
    Biochim Biophys Acta; 2006 Jan; 1758(1):45-54. PubMed ID: 16458850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Large ring 1,3-bridged 2-azetidinones: experimental and theoretical studies.
    Urbach A; Dive G; Tinant B; Duval V; Marchand-Brynaert J
    Eur J Med Chem; 2009 May; 44(5):2071-80. PubMed ID: 19038477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Ezetimibe--intestinal cholesterol absorbtion inhibitor].
    Pikto-Pietkiewicz W; Pasierski T
    Kardiol Pol; 2006 Dec; 64(12):1434-41. PubMed ID: 17206545
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.